Replay available

Adaptive Biotechnologies Corporation (ADPT) Q1 2026 Earnings Call

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) Q1 2026 earnings conference call, held 2026-05-05. Replay captured from the company's public earnings webcast.

Tue, May 5, 2026 at 4:30 PMendedReplay
Adaptive Biotechnologies Corporation (ADPT) Q1 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Karina Calcadilla

Head of Investor Relations

Chad Robbins

CEO & Co-founder

Kyle Piskill

Chief Financial Officer

Andrew Brackman

Analyst, William Blair

David Westenberg

Analyst, Piper Sandler

Mark Mazzaro

Analyst, BTIG

Subbu Namby

Analyst, Guggenheim

Sebastian Sandler

Analyst, JP Morgan

Dan Brennan

Analyst, TD Cowen

John Wilkin

Analyst, Craig-Hallum

Replay transcript excerpt

Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies first quarter financial results. At this time, all participants are in listen only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during this session, you will need to press 11 on your telephone. You would then hear an automated message advising your hand is raised. To withdraw your question, please press 11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Carina Calcadilla, Head of Investor Relations. Please go ahead. Thank you, Anton, and good afternoon, everyone. I would like to welcome you to Adaptive Biotechnologies First Quarter twenty twenty six Earnings Conference Call. Earlier today, we issued a press release reporting Adaptive financial results for the first quarter of twenty twenty six. The press release is available at www.adaptivebiotech.com. We are conducting a live webcast of this call and will be referencing to a slide presentation that has been posted to the Investors section in our corporate website. During the call, management will make projections and other forward looking statements within the meaning of federal security laws regarding future events and the future financial performance of the company. These statements reflect management's current perspective of the business as of today. Actual results may differ materially from today's forward looking statements depending on a number of factors, which are set forth in our public filings with the SEC and listed in this presentation. In addition, non GAAP financial measures will be discussed during the call and a reconciliation from non GAAP to GAAP metrics can be found in...

More from Adaptive Biotechnologies Corporation